Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Journal
Identifier:
E204602
ISSN:
2152-2650
  • Overview

Overview

Outputs (14)

  • ascendant
  • decrescent
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study
Academic Article
ATR addiction in Multiple Myeloma: synthetic lethal approaches exploiting established therapies
Abstract
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study
Abstract
CLL-114 BRUIN CLL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)
Academic Article
CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study
Academic Article
CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL)
Academic Article
CLL-418 Characteristics and Clinical Outcomes of Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Long-Term Ibrutinib Treatment in the RESONATE-2 Study
Academic Article
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
Academic Article
Diagnostic and Clinical Impact of Staging F-18-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience
Academic Article
Exploiting fiber-rich diet to perturb the microbiota-immune axis and thwart multiple myeloma progression
Academic Article
Exploiting microbiota commensals to potentiate immunotherapy and delay multiple myeloma evolution
Academic Article
FAM46C-dependent tuning of endoplasmic reticulum capacity in Multiple Myeloma
Abstract
Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates
Academic Article
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
Academic Article
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0